 |
|
Restoring Balance to Industry-Academia Relationships in an Era of Institutional Financial Conflicts of Interest
Promoting Research While Maintaining Trust
Michael M. E. Johns, MD;
Mark Barnes, JD, LLM;
Patrik S. Florencio, LLB, BCL
JAMA. 2003;289:741-746.
Economic partnerships between industry and academia accelerate medical innovation and enhance patient access to medical advances, but such partnerships have sometimes eroded public trust in the research enterprise. There is particular risk for conflict of interest when economic partnerships extend beyond a university's corporate interests to involve institutional decision makers. Institutions and institutional decision makers should fully disclose industry-related financial interests and relationships. Without legitimate justification for such interests, individuals should divest themselves from these interests or recuse themselves from responsibility for research oversight. Management of institutional partnerships also might entail the physical separation of certain facilities, the placement of restrictions on information shared between investment and research staffs, and provision of oversight by independent review panels made up of persons who have expertise in intellectual property, finance, and research, but who are not financially or otherwise dependent on the institution. Through these means, it is possible to restore balance to industry-academia relationships, thereby promoting progress while maintaining public trust in research.
Author Affiliations: Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Ga (Dr Johns); Health Care Group, Ropes & Gray, New York, NY (Mssrs Barnes and Florencio).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Responses of Medical Schools to Institutional Conflicts of Interest
Ehringhaus et al.
JAMA 2008;299:665-671.
ABSTRACT
| FULL TEXT
Origin and funding of the most frequently cited papers in medicine: database analysis
Patsopoulos et al.
BMJ 2006;332:1061-1064.
ABSTRACT
| FULL TEXT
Regulating Academic-Industrial Research Relationships -- Solving Problems or Stifling Progress?
Stossel
NEJM 2005;353:1060-1065.
FULL TEXT
Industry Funding of Clinical Trials: Benefit or Bias?
Chopra
JAMA 2003;290:113-114.
FULL TEXT
Handling Conflicts of Interest Between Industry and Academia
Egilman and Ehrle
JAMA 2003;289:3240-3240.
FULL TEXT
The "Price" of Information
Heinig
J Hum Lact 2003;19:133-135.
The power of clinical trials and guidelines,and the challenge of conflicts of interest
Bruce Fye
J Am Coll Cardiol 2003;41:1237-1242.
FULL TEXT
|
